Miguel de la Fuente
Overview
Explore the profile of Miguel de la Fuente including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
113
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hernandez-Fernandez F, Martinez-Fernandez I, Barbella-Aponte R, Vilar I, Ayo-Martin O, Garcia-Garcia J, et al.
Ann Clin Transl Neurol
. 2024 Dec;
12(1):235-241.
PMID: 39729628
Iatrogenic cerebral amyloid angiopathy, a disease caused by contact with neurosurgical material or human growth hormone contaminated by beta-amyloid peptide (Aβ), has a prion-like transmission mechanism. We present a series...
2.
de la Fuente M, Delgado D, Beitia M, Barreda-Gomez G, Acera A, Sanchez M, et al.
BMC Biotechnol
. 2024 Jul;
24(1):50.
PMID: 39030513
Background: Measuring collagenase activity is crucial in the field of joint health and disease management. Collagenases, enzymes responsible for collagen degradation, play a vital role in maintaining the balance between...
3.
Bartha I, de la Fuente M, Martinez-Sanchez N, de la Calle M, Martin Boado E, Bartha J
Acta Obstet Gynecol Scand
. 2023 Aug;
102(11):1593-1601.
PMID: 37602745
Introduction: Air pollution is a current major health issue. The burden of airborne pollutants and aeroallergen levels varies throughout the year, as well as their interaction and consequences. Prenatal exposure...
4.
de Los Bueis A, de la Fuente M, Montejano-Milner R, Del Hierro Zarzuelo A, Vecino E, Acera A
Curr Issues Mol Biol
. 2023 May;
45(4):2881-2894.
PMID: 37185712
Ocular diseases have a strong impact on individuals, the effects of which extend from milder visual impairment to blindness. Due to this and to their prevalence, these conditions constitute important...
5.
Cromb D, Slator P, de la Fuente M, Price A, Rutherford M, Egloff A, et al.
Magn Reson Med
. 2023 May;
90(3):1137-1150.
PMID: 37183839
Purpose: Studying placental development informs when development is abnormal. Most placental MRI studies are cross-sectional and do not study the extent of individual variability throughout pregnancy. We aimed to explore...
6.
Garro-Aguilar Y, Fernandez R, Calero S, Noskova E, Gulak M, de la Fuente M, et al.
Molecules
. 2023 Feb;
28(3).
PMID: 36770644
Producers of milk and dairy products have been faced with the challenge of responding to European society's demand for guaranteed animal welfare production. In recent years, measures have been taken...
7.
Bartha I, de la Fuente M, de la Calle M, Martin Boado E, Martinez-Sanchez N, Bartha J
Int J Gynaecol Obstet
. 2022 Nov;
161(2):509-516.
PMID: 36334064
Objective: To evaluate the influence of respiratory allergy on obstetrics and perinatal outcomes. Methods: A nested case-control retrospective study on 41 035 pregnant women. Obstetrics and perinatal outcomes of women...
8.
de la Fuente M, Rodriguez-Agirretxe I, Vecino E, Astigarraga E, Acera A, Barreda-Gomez G
Int J Mol Sci
. 2022 May;
23(10).
PMID: 35628448
Matrix metalloproteinases are a family of enzymes fundamental in inflammatory processes. Between them, MMP-9 is up-regulated during inflammation; thus, its quantification in non-invasive fluids is a promising approach for inflammation...
9.
Martinez-Cortes M, Leon-Dominguez C, Fernandez-Pinero J, Rodriguez M, Almonacid M, Ferrari M, et al.
Occup Environ Med
. 2021 Oct;
79(5):295-303.
PMID: 34599009
Objectives: To study prevalence of infection in essential workers of Madrid City Council by occupation, related characteristics, use of protective devices, risk perception, and main concerns about COVID-19 during lockdown....
10.
de la Fuente M, Lombardero L, Gomez-Gonzalez A, Solari C, Angulo-Barturen I, Acera A, et al.
Int J Mol Sci
. 2021 Sep;
22(17).
PMID: 34502086
In recent years, enzymes have risen as promising therapeutic tools for different pathologies, from metabolic deficiencies, such as fibrosis conditions, ocular pathologies or joint problems, to cancer or cardiovascular diseases....